Emerging infectious diseases · 2019
Epidemiologic and Clinical Features of Lassa Fever Outbreak in Nigeria, January 1-May 6, 2018.
Историческая статьяСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Ilori Elsie A, Furuse Yuki, Ipadeola Oladipupo B, Dan-Nwafor Chioma C, Abubakar Anwar, Womi-Eteng Oboma E, Ogbaini-Emovon Ephraim, Okogbenin Sylvanus, Unigwe Uche, Ogah Emeka, Ayodeji Olufemi, Abejegah Chukwuyem, Liasu Ahmed A, Musa Emmanuel O, Woldetsadik Solomon F, Lasuba Clement L P, Alemu Wondimagegnehu, Ihekweazu Chikwe, Nigeria Lassa Fever National Response Team
Аннотация
Lassa fever (LF) is endemic to Nigeria, where the disease causes substantial rates of illness and death. In this article, we report an analysis of the epidemiologic and clinical aspects of the LF outbreak that occurred in Nigeria during January 1-May 6, 2018. A total of 1,893 cases were reported; 423 were laboratory-confirmed cases, among which 106 deaths were recorded (case-fatality rate 25.1%). Among all confirmed cases, 37 occurred in healthcare workers. The secondary attack rate among 5,001 contacts was 0.56%. Most (80.6%) confirmed cases were reported from 3 states (Edo, Ondo, and Ebonyi). Fatal outcomes were significantly associated with being elderly; no administration of ribavirin; and the presence of a cough, hemorrhaging, and unconsciousness. The findings in this study should lead to further LF research and provide guidance to those preparing to respond to future outbreaks.